ReviewClinical microbiology reviews1988
Clinical laboratory applications of monoclonal antibodies.
Review in Clinical microbiology reviews, 1988. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Article
- Turntable Paper-Based Device to DetectMicromachines · 2021Article
- Efficient detection of eukaryotic calcium-sensing receptor (CaSR) by polyclonal antibody against prokaryotic expressed truncated CaSR.Molecular biology reports · 2020Article
- Affimers as an Alternative to Antibodies in an Affinity LC-MS Assay for Quantification of the Soluble Receptor of Advanced Glycation End-Products (sRAGE) in Human Serum.Journal of proteome research · 2018Article
- Novel high-throughput cell-based hybridoma screening methodology using the Celigo Image Cytometer.Journal of immunological methods · 2017Article
- Antibody-like Biorecognition Sites for Proteins from Surface Imprinting on Nanoparticles.ACS applied materials & interfaces · 2015Article
- Expression and characterization of an enantioselective antigen-binding fragment directed against α-amino acids.Protein expression and purification · 2013Article
- Phase behavior of an intact monoclonal antibody.Biophysical journal · 2007Article
- Rational monoclonal antibody development to emerging pathogens, biothreat agents and agents of foreign animal disease: The antigen scale.Veterinary journal (London, England : 1997) · 2005Review
- Immunological methods for detection and identification of infectious disease and biological warfare agents.Clinical and diagnostic laboratory immunology · 2003Review
- Comparison of various detection methods for periodontopathic bacteria: can culture be considered the primary reference standard?Journal of clinical microbiology · 1992Article
- Chancroid and Haemophilus ducreyi.Clinical microbiology reviews · 1989Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Monoclonal antibody (MAb) technology is well recognized as a significant development for producing specific serologic reagents to a wide variety of antigens in unlimited amounts. These reagents have provided the means for developing a number of highly specific and reproducible immunological assays for rapid and accurate diagnosis of an extensive list of diseases, including infectious diseases. The impact that MAbs have had in characterizing infectious disease pathogens, as well as their current and future applications for use in clinical microbiology laboratories, is reviewed. In addition, the advantages (and disadvantages) of the use of MAbs in a number of immunoassays, such as particle agglutination, radioimmunoassays, enzyme-linked immunosorbent assays, immunofluorescent-antibody assays, and immunohistology, are explored, including the use of these reagents in novel test system assays. Also, nucleic acid probe technology is compared with the use of MAbs from the perspective of their respective applications in the diagnosis of infectious disease agents. There is no question that hybridoma technology has the potential to alter significantly the methods currently used in most clinical microbiology laboratories.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.